|
CN112079932A
|
|
Chimeric antigen receptor for treating liver cancer and application thereof
|
|
CN111892661A
|
|
Chimeric antigen receptor and application thereof in preparation of products for treating tumors
|
|
CN111875708A
|
|
Chimeric antigen receptor T lymphocyte and application thereof in preparation of product for treating solid tumor
|
|
CN111474339A
|
|
Method for labeling poxvirus particles by fluorescence and application thereof
|
|
CN111235158A
|
|
Viral vector for expressing recombinant human β -globin and application thereof
|
|
CN111876437A
|
|
Chimeric antigen receptor for targeting CD19 and interferon synergy and application thereof
|
|
CN111850013A
|
|
Chimeric antigen receptor with synergistic co-stimulation receptor and application thereof
|
|
CN111850014A
|
|
Chimeric antigen receptor with synergistic cytokine and application thereof
|
|
CN109331021A
|
|
Application of the PARP1 inhibitor in preparation tumour immunotherapy preparation
|
|
CN109187982A
|
|
A kind of screening of TLR class vaccine adjuvant and identification method
|
|
CN109172818A
|
|
A kind of albumen varicella vaccine and its effect detection method
|
|
CN108486053A
|
|
A kind of method of efficient amplification in vitro peripheral blood NK cell
|
